Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

about

Takotsubo syndrome in a patient after renal transplantation.

P2860

Q36577479-B001F3D2-465D-43D8-8F69-CE111F396372

P2860

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

Item

http://www.wikidata.org/entity/Q42959387

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Can cardiac iodine-123 metaiod ...... ion in heart failure patients?

@en

Can cardiac iodine-123 metaiod ...... ion in heart failure patients?

@nl

type

Item

label

Can cardiac iodine-123 metaiod ...... ion in heart failure patients?

@en

Can cardiac iodine-123 metaiod ...... ion in heart failure patients?

@nl

prefLabel

Can cardiac iodine-123 metaiod ...... ion in heart failure patients?

@en

Can cardiac iodine-123 metaiod ...... ion in heart failure patients?

@nl

P1476

Can cardiac iodine-123 metaiod ...... ion in heart failure patients?

@en

P2093

Mark Boogers

http://www.w3.org/2001/XMLSchema#string

Maureen M Henneman

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study

Cardiac neurotransmission imaging.

Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography.

Cardiac neurotransmission SPECT imaging.

Assessment of cardiac sympathetic neuronal function using PET imaging.

I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.

Chronic heart failure in the United States: a manifestation of coronary artery disease.

Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure.

Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography.

Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

P2888

s00259-008-0722-4

P304

532-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S00259-008-0722-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeroen Joost Bax

P577

2008-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5641839

http://www.w3.org/2001/XMLSchema#string

P698

18210105

http://www.w3.org/2001/XMLSchema#string

P932

2275775

http://www.w3.org/2001/XMLSchema#string

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

about

P2860

P2860

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932